These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 28533092

  • 1. Thiol-reactive drug substrates of human P-glycoprotein label the same sites to activate ATPase activity in membranes or dodecyl maltoside detergent micelles.
    Loo TW, Clarke DM.
    Biochem Biophys Res Commun; 2017 Jul 08; 488(4):573-577. PubMed ID: 28533092
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.
    Loo TW, Bartlett MC, Clarke DM.
    Biochem J; 2006 Oct 15; 399(2):351-9. PubMed ID: 16813563
    [Abstract] [Full Text] [Related]

  • 5. Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites.
    Loo TW, Bartlett MC, Clarke DM.
    J Biol Chem; 2003 Dec 12; 278(50):50136-41. PubMed ID: 14522974
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site.
    Loo TW, Bartlett MC, Clarke DM.
    J Biol Chem; 2003 Jun 06; 278(23):20449-52. PubMed ID: 12711602
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein.
    Loo TW, Clarke DM.
    J Biol Chem; 2015 Dec 04; 290(49):29389-401. PubMed ID: 26507655
    [Abstract] [Full Text] [Related]

  • 10. The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison.
    Weinheimer M, Fricker G, Burhenne J, Mylius P, Schubert R.
    Eur J Pharm Sci; 2017 Oct 15; 108():13-22. PubMed ID: 27590127
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.
    Loo TW, Bartlett MC, Clarke DM.
    J Biol Chem; 2003 Oct 10; 278(41):39706-10. PubMed ID: 12909621
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Functional role of the linker region in purified human P-glycoprotein.
    Sato T, Kodan A, Kimura Y, Ueda K, Nakatsu T, Kato H.
    FEBS J; 2009 Jul 10; 276(13):3504-16. PubMed ID: 19490125
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
    Chen KG, Lacayo NJ, Durán GE, Cohen D, Sikic BI.
    Mol Pharmacol; 2000 Apr 10; 57(4):769-77. PubMed ID: 10727524
    [Abstract] [Full Text] [Related]

  • 20. Large-scale purification of functional human P-glycoprotein (ABCB1).
    Nandigama K, Lusvarghi S, Shukla S, Ambudkar SV.
    Protein Expr Purif; 2019 Jul 10; 159():60-68. PubMed ID: 30851394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.